flestolol
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Changes in heart rate induced by four different doses of two
newly synthetized potential ultrashort-action antagonists of
beta…
Flestolol, N(1,1-dimethyl-2-ureidocthyl)-2-hydroxy-3-(o-fluorobenzoyloxy++ +) propylamine, (F), is an ester containing an ultra…
Flestolol, N(1,1-dimethyl-2-ureidocthyl)-2-hydroxy-3-(o-fluorobenzoyloxy++ +) propylamine, (F), is an ester containing an ultra…
The blood esterase that mediates the metabolism of flestolol, an ultra short-acting beta blocker, was characterized. Esterase…
The blood esterase that mediates the metabolism of flestolol, an ultra short-acting beta blocker, was characterized. Esterase…
The hemodynamic effects of flestolol were evaluated in 30 patients undergoing routine cardiac catheterization. Hemodynamic…
The pharmacokinetics and pharmacodynamics of flestolol, a new short‐acting, beta‐adrenergic receptor antagonist, were examined in…
The tolerance and β‐adrenergic blocking activity of flestolol, a short‐acting β‐blocker, was investigated in 30 subjects…
The steady state pharmacokinetics of flestolol, a short acting beta-adrenoceptor blocking agent, were studied in six healthy…
The β-adrenergic receptor blocking properties of ACC-9089 were studied in isolated cardiac and tracheal tissues from guinea pigs…